Daniel Iriepa-Diez
Madrid, MD 28006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 30, 2026
N-Methyl-N-((1-methyl-5-(3-(piperidin-1-yl)propoxy)-1H-benzo[d]imidazol-2-yl)methyl)prop-2-yn-1-amine (MBA-159), a new multitarget small molecule for the therapy of Alzheimer's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 28, 2025
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases.
Journal: Acta pharmaceutica Sinica. B
Published: August 30, 2022
Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment.
Journal: Antioxidants (Basel, Switzerland)
Published: August 09, 2022
Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes.
Journal: Antioxidants (Basel, Switzerland)
Published: July 18, 2022
Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout.
Journal: Journal of medicinal chemistry
Published: April 11, 2022
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 05, 2021
Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors.
Journal: RSC medicinal chemistry
Published: March 23, 2021
Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models.
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2021
Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties.
Journal: International journal of molecular sciences
Published: October 05, 2020
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
Journal: Chemical record (New York, N.Y.)
Published: September 04, 2020
Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy.
Journal: Molecules (Basel, Switzerland)
Published: June 22, 2020
Last Updated: 09/26/2026